Characterization of patients that can continue conservative treatment for adenomyosis

Chiho Miyagawa, Kosuke Murakami, Takako Tobiume, Takafumi Nonogaki, Noriomi Matsumura
doi: https://doi.org/10.1101/2021.03.03.21252870

Article Information

doi 
https://doi.org/10.1101/2021.03.03.21252870
History 
  • March 6, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Chiho Miyagawa, M.D.1,2,
  2. Kosuke Murakami, M.D.1,*,
  3. Takako Tobiume, M.D., Ph.D.3,
  4. Takafumi Nonogaki, M.D., Ph.D.2 and
  5. Noriomi Matsumura, M.D., Ph.D.1
  1. 1Department of Obstetrics and Gynecology, Kindai University Faculty of Medicine, Osaka-sayama, Osaka, Japan
  2. 2Department of Obstetrics and Gynecology, Osaka Red Cross Hospital, Osaka, Japan
  3. 3Department of Obstetrics and Gynecology, National Hospital Organization Osaka National Hospital, Osaka, Japan
  1. ↵*Corresponding author: Kosuke Murakami, Department of Obstetrics and Gynecology, Kindai University Faculty of Medicine, 377-2, Ohnohigashi, Osaka-sayama, Osaka, Japan, 589-8511, E-mail: kmurakami{at}med.kindai.ac.jp
Back to top
Posted March 06, 2021.
Download PDF
Data/Code
Email
Characterization of patients that can continue conservative treatment for adenomyosis
Chiho Miyagawa, Kosuke Murakami, Takako Tobiume, Takafumi Nonogaki, Noriomi Matsumura
medRxiv 2021.03.03.21252870; doi: https://doi.org/10.1101/2021.03.03.21252870
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area